Drug list
CENTRAL NERVOUS SYSTEM DRUGS › MISCELLANEOUS CENTRAL NERVOUS SYSTEM DRUGS

ACAMPROSATE CALCIUM (Campral)

333mgDR Tab
LU531
QUICK SCAN

For the treatment of alcohol use disorder in patients who: Meet clinical criteria for alcohol use disorder; and Express a commitment to abstain from alcohol; and Have been abstinent from alcohol for at least 3 days prior to starting acamprosate; and

LU Authorization Period: 1 year
Complete Ontario criteria

For the treatment of alcohol use disorder in patients who: - Meet clinical criteria for alcohol use disorder; and - Express a commitment to abstain from alcohol; and - Have been abstinent from alcohol for at least 3 days prior to starting acamprosate; and - Have confirmed participation in counselling and treatment for alcohol use disorder* * An individualized treatment plan will have one or more of the following components: Counselling and follow-up with the patient's family physician, addiction physician, or psychiatrist; self-help groups such as Alcoholics Anonymous; and outpatient, day, or inpatient psychosocial rehabilitation programs.

Clinical verification required

Quick summaries support scanning only. Confirm eligibility against the complete Ontario criteria and current Ontario e-Formulary before billing.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.